Pulse Biosciences (PLSE) Notes Payables (2021 - 2023)

Pulse Biosciences (PLSE) posted quarterly Notes Payables of $801000.0 for Q1 2023, down 12.65% quarter-over-quarter from $917000.0 in Q4 2022.

Pulse Biosciences (PLSE) Notes Payables (2021 - 2023) Analysis & Trends

Pulse Biosciences' Notes Payables history runs 3 years deep, the most recent figure standing at $801000.0 for Q1 2023.

In Q1 2023, Notes Payables changed N/A year-over-year to $801000.0; the TTM figure through Mar 2023 stood at $801000.0 (changed N/A YoY), while the FY2022 annual figure was $917000.0, changed N/A from the prior year.
Notes Payables for Q1 2023 stood at $801000.0, down from $917000.0 in the prior quarter.
The five-year high for Notes Payables was $1.7 million in Q2 2021, with the low at $98000.0 in Q3 2022.
The 3-year median for Notes Payables is $859000.0 (2022), against an average of $791666.7.
Peak annual rise in Notes Payables reached 90.98% in 2022, while the deepest fall reached 90.98% in 2022.
Pulse Biosciences' Notes Payables stood at $1.1 million in 2021, then declined by 15.56% to $917000.0 in 2022, then declined by 12.65% to $801000.0 in 2023.
Business Quant data shows PLSE's Notes Payables at $801000.0 in Q1 2023, $917000.0 in Q4 2022, and $98000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn
10	Pulse Biosciences	3.33 Bn	3.33 Bn	161,000.00

Download Data